Cargando…
Subacute Intranasal Administration of Tissue Plasminogen Activator Promotes Neuroplasticity and Improves Functional Recovery following Traumatic Brain Injury in Rats
Traumatic brain injury (TBI) is a major cause of death and long-term disability worldwide. To date, there are no effective pharmacological treatments for TBI. Recombinant human tissue plasminogen activator (tPA) is the effective drug for the treatment of acute ischemic stroke. In addition to its thr...
Autores principales: | Meng, Yuling, Chopp, Michael, Zhang, Yanlu, Liu, Zhongwu, An, Aaron, Mahmood, Asim, Xiong, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153585/ https://www.ncbi.nlm.nih.gov/pubmed/25184365 http://dx.doi.org/10.1371/journal.pone.0106238 |
Ejemplares similares
-
Plasminogen Deficiency Causes Reduced Corticospinal Axonal Plasticity and Functional Recovery after Stroke in Mice
por: Liu, Zhongwu, et al.
Publicado: (2014) -
Emerging potential of exosomes for treatment of traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2017) -
Remodeling dendritic spines for treatment of traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2019) -
Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities
por: Xiong, Ye, et al.
Publicado: (2018) -
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration
por: Xiong, Ye, et al.
Publicado: (2023)